Stock listing
NASDAQ:NEUP Neuphoria Therapeutics Inc. Stock
Home listing (NASDAQ) of Neuphoria Therapeutics Inc.
Follow Neuphoria Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:NEUP
$3.39 USD +0.08 (+2.4%)
Close on Oct 20, 2026
- Day range
- $3.33 – $3.40 USDOct 20, 2026
- Volume
- 20,808 sharesOct 20, 2026
- Market cap
- $18.34M USDAt the close on Oct 20, 2026 · price × 5.41M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NEUP · Home | $3.39 USD | +0.08 (+2.4%) | 20,808 | $3.365 | $3.40 | $3.33 | $3.31 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:NEUP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.39 | +0.08 | +2.4% | $3.365 | $3.40 | $3.33 | 20,808 | |
| $3.31 | +0.01 | +0.3% | $3.24 | $3.41 | $3.24 | 39,075 | |
| $3.30 | -0.01 | -0.3% | $3.35 | $3.41 | $3.24 | 73,047 | |
| $3.31 | +0.07 | +2.2% | $3.25 | $3.42 | $3.25 | 18,748 | |
| $3.24 | -0.15 | -4.4% | $3.32 | $3.37 | $3.24 | 45,955 | |
| $3.39 | +0.07 | +2.1% | $3.49 | $3.49 | $3.32 | 26,636 | |
| $3.32 | -0.04 | -1.2% | $3.32 | $3.38 | $3.32 | 9,963 | |
| $3.36 | +0.01 | +0.3% | $3.33 | $3.41 | $3.32 | 2,500 | |
| $3.35 | -0.07 | -2.0% | $3.40 | $3.42 | $3.34 | 16,500 | |
| $3.42 | -0.03 | -0.9% | $3.40 | $3.45 | $3.40 | 4,500 | |
| $3.45 | 0.00 | 0.0% | $3.45 | $3.50 | $3.43 | 16,500 | |
| $3.45 | -0.02 | -0.6% | $3.45 | $3.50 | $3.43 | 15,500 | |
| $3.47 | -0.04 | -1.1% | $3.51 | $3.59 | $3.45 | 12,600 | |
| $3.51 | -0.05 | -1.4% | $3.525 | $3.54 | $3.50 | 14,300 | |
| $3.56 | -0.01 | -0.3% | $3.60 | $3.615 | $3.53 | 10,400 | |
| $3.57 | -0.08 | -2.2% | $3.64 | $3.65 | $3.57 | 15,000 | |
| $3.65 | 0.00 | 0.0% | $3.67 | $3.69 | $3.65 | 2,900 | |
| $3.65 | 0.00 | 0.0% | $3.67 | $3.67 | $3.65 | 1,300 | |
| $3.65 | -0.03 | -0.8% | $3.67 | $3.70 | $3.65 | 5,400 | |
| $3.68 | -0.055 | -1.5% | $3.69 | $3.755 | $3.66 | 15,500 | |
| $3.735 | +0.025 | +0.7% | $3.73 | $3.77 | $3.71 | 6,700 | |
| $3.71 | +0.01 | +0.3% | $3.69 | $3.79 | $3.68 | 17,900 | |
| $3.70 | -0.015 | -0.4% | $3.712 | $3.83 | $3.70 | 21,600 | |
| $3.715 | -0.025 | -0.7% | $3.79 | $3.79 | $3.71 | 5,300 | |
| $3.74 | -0.04 | -1.1% | $3.72 | $3.81 | $3.72 | 36,800 | |
| $3.78 | -0.02 | -0.5% | $3.75 | $3.80 | $3.73 | 17,700 | |
| $3.80 | +0.07 | +1.9% | $3.78 | $3.84 | $3.74 | 12,400 | |
| $3.73 | 0.00 | 0.0% | $3.78 | $3.78 | $3.72 | 23,000 | |
| $3.73 | -0.02 | -0.5% | $3.79 | $3.793 | $3.70 | 43,000 | |
| $3.75 | 0.00 | 0.0% | $3.795 | $3.865 | $3.75 | 18,600 | |
| $3.75 | -0.02 | -0.5% | $3.84 | $3.84 | $3.72 | 22,600 | |
| $3.77 | +0.01 | +0.3% | $3.74 | $3.78 | $3.73 | 21,900 | |
| $3.76 | +0.01 | +0.3% | $3.84 | $3.84 | $3.742 | 7,300 | |
| $3.75 | -0.04 | -1.1% | $3.84 | $3.84 | $3.75 | 17,900 | |
| $3.79 | +0.03 | +0.8% | $3.73 | $3.81 | $3.73 | 20,800 | |
| $3.76 | 0.00 | 0.0% | $3.71 | $3.815 | $3.71 | 52,200 | |
| $3.76 | -0.01 | -0.3% | $3.72 | $3.835 | $3.72 | 29,900 | |
| $3.77 | -0.09 | -2.3% | $3.84 | $3.90 | $3.71 | 50,100 | |
| $3.86 | 0.00 | 0.0% | $3.86 | $3.995 | $3.854 | 41,000 | |
| $3.86 | -0.09 | -2.3% | $3.93 | $3.96 | $3.85 | 33,600 | |
| $3.95 | +0.04 | +1.0% | $3.90 | $4.01 | $3.90 | 57,900 | |
| $3.91 | -0.04 | -1.0% | $3.98 | $4.05 | $3.91 | 179,800 | |
| $3.95 | +0.02 | +0.5% | $3.98 | $4.00 | $3.92 | 55,700 | |
| $3.93 | -0.05 | -1.3% | $4.03 | $4.03 | $3.93 | 23,800 | |
| $3.98 | +0.13 | +3.4% | $3.85 | $4.34 | $3.83 | 240,500 | |
| $3.85 | -0.02 | -0.5% | $3.91 | $3.97 | $3.781 | 23,000 | |
| $3.87 | +0.04 | +1.0% | $3.83 | $3.90 | $3.80 | 23,700 | |
| $3.83 | +0.02 | +0.5% | $3.77 | $3.88 | $3.77 | 8,900 | |
| $3.81 | 0.00 | 0.0% | $3.79 | $3.87 | $3.75 | 33,800 | |
| $3.81 | -0.05 | -1.3% | $3.81 | $3.86 | $3.80 | 30,400 | |
| $3.86 | +0.04 | +1.0% | $3.81 | $3.89 | $3.81 | 15,500 | |
| $3.82 | -0.08 | -2.1% | $3.88 | $3.98 | $3.82 | 9,600 | |
| $3.90 | -0.05 | -1.3% | $3.92 | $4.10 | $3.83 | 29,700 | |
| $3.95 | +0.06 | +1.5% | $3.89 | $3.99 | $3.84 | 40,900 | |
| $3.89 | -0.04 | -1.0% | $3.89 | $3.98 | $3.88 | 42,000 | |
| $3.93 | +0.05 | +1.3% | $3.86 | $4.05 | $3.75 | 57,900 | |
| $3.88 | -0.04 | -1.0% | $3.90 | $4.00 | $3.872 | 37,300 | |
| $3.92 | +0.12 | +3.2% | $3.80 | $4.06 | $3.73 | 71,000 | |
| $3.80 | -0.01 | -0.3% | $3.85 | $3.92 | $3.77 | 81,200 | |
| $3.81 | -0.04 | -1.0% | $3.88 | $3.91 | $3.71 | 97,100 | |
| $3.85 | +0.21 | +5.8% | $3.73 | $4.021 | $3.60 | 205,500 | |
| $3.64 | -0.28 | -7.1% | $3.86 | $3.90 | $3.54 | 392,800 | |
| $3.92 | +0.59 | +17.7% | $3.80 | $4.20 | $3.68 | 7,623,600 | |
| $3.33 | -0.01 | -0.3% | $3.39 | $3.42 | $3.28 | 47,400 | |
| $3.34 | +0.04 | +1.2% | $3.39 | $3.55 | $3.31 | 47,300 | |
| $3.30 | -0.115 | -3.4% | $3.40 | $3.485 | $3.30 | 71,100 |
- Ticker
- NASDAQ:NEUP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Jul 23, 2026
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
Latest deck · Jul 24, 2026
Investor Presentation (July 2026)
Investor deck · 35 slides
Latest news
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
Jul 23, 2026
Closed $3.92 (+17.7%) on Jul 23, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 35 slides · Jul 24, 2026
Proxy Contest (November 2025)
Proxy contest · 18 slides · Nov 26, 2025
Proxy Contest (November 2025)
Proxy contest · 25 slides · Nov 25, 2025
Investor Presentation (2025)
Investor deck · 40 slides · 2025
Neuphoria Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 9 in the last 12 months · 79 in all · newest Jul 23, 2026 · oldest 2021
- Decks
- 5 decks · latest Jul 24, 2026
Where Neuphoria Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NEUP · Home listing · This page | NASDAQ | United States | USD |
| BOATS:NEUP | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Neuphoria Therapeutics Inc.